13 February 2025
\n \n \n \nNDM\u2019s Pandemic Sciences Institute and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics \u2013 as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
\n \n\n \n \n12 February 2025
\n \n \n \nFive members of the MSc Genomic Medicine teaching team have been awarded Advanced HE fellowships in recognition of their roles in teaching and supporting higher education learning.
\n \n\n \n \n11 February 2025
\n \n \n \nInternational Day of Women and Girls in Science serves as a reminder of the gender disparities that persist in the Science, Technology, Engineering and Mathematics (STEM) fields.
\n \n\n \n \n6 February 2025
\n \n \n \nThe Rt Hon Anneliese Dodds MP, Minister of State for Development, Minister of State for Women and Equalities and Oxford East MP, visited the Jenner Institute last week to discuss the very latest in malaria vaccine science.
\n \n\n \n \n5 February 2025
\n \n \n \nDr Matthew Bottomley from the CAMS Oxford Institute has been selected as the January winner of Cancer Research UK\u2019s Research is Beautiful Photography campaign.
\n \n\n \n \n3 February 2025
\n \n \n \nResearchers in NDM have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
\n \n\n \n \n31 January 2025
\n \n \n \nResearchers in the Nuffield Department of Medicine and their collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial. The new method analyses the vaccine vial label and its adhesive and therefore allows genuine vaccine vials to be retained in the supply chain. This technique can also differentiate genuine Covid-19 vaccine liquid from falsified vaccine surrogates.
\n \n\n \n \n30 January 2025
\n \n \n \nProfessor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology at NDM\u2019s Centre for Tropical Medicine and Global Health and the Big Data Institute, looks at potential ways to advance research on the impact of climate change on malaria and neglected tropical diseases (NTDs).
\n \n\n \n \n27 January 2025
\n \n \n \nGlobal biopharma company GSK invests up to \u00a350 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
\n \n\n \n \n24 January 2025
\n \n \n \nThe University of Oxford has once again been named the top institution in the Times Higher Education (THE) Subject Rankings for Clinical, Pre-Clinical, and Health, marking an impressive 14th consecutive year in this prestigious position.
\n \n\n \n \n22 January 2025
\n \n \n \nNew research from NDM\u2019s Target Discovery Institute, the MRC Laboratory of Molecular Biology and University College London has shed light on a potential pathway for the spread of harmful tau protein in Alzheimer's disease. Their findings, published in Nature Neuroscience, focus on structures called extracellular vesicles and their role in transporting toxic tau fragments.
\n \n\n \n \n21 January 2025
\n \n \n \nResults of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.
\n \n\n \n \n20 January 2025
\n \n \n \nLed by Professor Yvonne Jones at the Division of Structural Biology and Professor David Strutt at the University of Sheffield's School of Biosciences, this \u00a33.7 million Wellcome Trust-funded project brings together cutting-edge technology and world-class expertise.
\n \n\n \n \n17 January 2025
\n \n \n \nResearchers have proposed a possible new strategy for rabies control policies. By building on pre-existing models, they have found that opting for pre-exposure prophylaxis could be an additional cost-effective tool for rabies management.
\n \n\n \n \n16 January 2025
\n \n \n \nDr Pablo F. C\u00e9spedes, CAMS Oxford Institute Career Development Fellow, has received funding from NC3Rs to establish a lymphoid organoid and explant hub for researchers across the country.
\n \n\n \n \n15 January 2025
\n \n \n \nThe Global Health Network has achieved a remarkable milestone: one million members worldwide. This dynamic and inclusive community of healthcare professionals and researchers is addressing two of the most pressing challenges in global health. By equipping teams to tackle everyday diseases of poverty and strengthening the ability to detect and respond to emerging threats, The Global Health Network is saving lives and safeguarding the future of global health.
\n \n\n \n \n14 January 2025
\n \n \n \nGroundbreaking research by scientists from the Centre for Medicines Discovery at the Nuffield Department of Medicine opens up new possibilities for developing treatments that could both fight cancer and regulate the immune system, offering hope for better and more precise therapies in the future.
\n \n\n \n \n13 January 2025
\n \n \n \nThe Department wishes to announce that Professor Dame Sarah Gilbert has been appointed to the role of Deputy Head of Department of the Nuffield Department of Medicine for a five-year term.
\n \n\n \n \n9 January 2025
\n \n \n \nAn important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.
\n \n\n \n \n8 January 2025
\n \n \n \nA new blood test \u2013 powered by machine learning \u2013 has shown real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect. Developed by a team of researchers and co-lead by the Centre for Human Genetics\u2019 Dr Dimitris Vavoulis, the test accurately detected six cancer types and could distinguish between people with and without cancer.
\n \n\n \n \n